Insulin degludec Subcutaneous and Loteprednol and tobramycin ophthalmic
Determining the interaction of Insulin degludec Subcutaneous and Loteprednol and tobramycin ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec Subcutaneous-Loteprednol Etabonate
- Insulin degludec Subcutaneous-Loteprednol Eye Drops
- Insulin degludec Subcutaneous-Loteprednol Eye Drops 0.2%
- Insulin degludec Subcutaneous-Loteprednol Eye Drops 0.5% and 1%
- Insulin degludec Subcutaneous-Loteprednol Eye Gel
- Insulin degludec Subcutaneous-Loteprednol Eye Ointment
- Loteprednol and tobramycin ophthalmic-Insulin detemir
- Loteprednol and tobramycin ophthalmic-Insulin Detemir (Cartridges and Prefilled Syringes)
- Loteprednol and tobramycin ophthalmic-Insulin Detemir (Vials)
- Loteprednol and tobramycin ophthalmic-Insulin detemir Subcutaneous
- Loteprednol and tobramycin ophthalmic-Insulin glargine
- Loteprednol and tobramycin ophthalmic-Insulin Glargine (U-100) Cartridge Systems and Pens